American Association for Cancer Research

Press Releases: 2012

Page:   1 2 3 4 5 6 7 8 9 10  next
Results Per Page 

Next-Generation Sequencing Test Identified Potential Targets for Pediatric Cancer Treatments

November 4, 2013

SAN DIEGO — A comprehensive genomic profiling test using next-generation sequencing has identified genomic alterations in more than half of...

New Biomarker May Help Guide Treatment of Melanoma Patients

October 22, 2013

BOSTON — A functional biomarker that can predict whether BRAF-mutant melanomas respond to drugs targeting BRAF could help guide the treatment...

AACR and Kure It Announce Two Kidney Cancer Research Grant Recipients

December 21, 2012

PHILADELPHIA — The American Association for Cancer Research and Kure It are pleased to announce that William Y. Kim, M.D., and James W. Mier,...

Preventing Prostate Cancer Through Androgen Deprivation May Have Harmful Effects

December 20, 2012

PHILADELPHIA — The use of androgen deprivation therapies to prevent precancerous prostate abnormalities developing into aggressive prostate...

AACR Appoints Rick Buck as Senior Director of Communications and Public Relations

December 19, 2012

PHILADELPHIA — The American Association for Cancer Research has appointed Rick Buck as senior director of communications and public relations....

AACR's Cancer Today Magazine Received the 2012 Silver Ozzie Award

December 18, 2012

PHILADELPHIA — Cancer Today, a publication of the American Association for Cancer Research that provides information and inspiration to cancer...

Hard-to-treat Myc-driven Cancers May Be Susceptible to Drug Already Used in Clinic

December 14, 2012

PHILADELPHIA — Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling...

New Screening Approach Identified Potential Drug Combinations for Difficult-to-treat Forms of Melanoma

December 13, 2012

PHILADELPHIA — A novel approach to identifying potential anticancer drug combinations revealed that pairing cholesterol-reducing drugs called...

Stand Up To Cancer and Cancer Research Institute Announce New Immunology Translational Research Dream Team

December 12, 2012

PHILADELPHIA — Stand Up To Cancer (SU2C) and the Cancer Research Institute (CRI) announce the formation of a Dream Team project dedicated to...

Obesity and Overeating During Menopause Together Promote Breast Tumor Growth and Progression

December 7, 2012

PHILADELPHIA — Obese women might be able to eliminate their increased risk for postmenopausal breast cancer by taking measures during...

Extending Adjuvant Trastuzumab Treatment Time Provided No Additional Benefit

December 7, 2012

SAN ANTONIO — One year of adjuvant trastuzumab should remain the standard of care for patients with HER2-postive early-stage breast cancer,...

Phase III Trial Did Not Show Superiority of Eribulin Compared With Capecitabine in Metastatic Breast Cancer

December 7, 2012

SAN ANTONIO — A phase III multicenter study of eribulin mesylate in women with previously treated metastatic breast cancer failed to meet its...

Cognitive Problems May Be Present Before Chemotherapy in Women With Breast Cancer

December 7, 2012

SAN ANTONIO — Women undergoing chemotherapy who experience cognitive problems, commonly referred to as “chemo brain,” displayed...

Adjuvant Bevacizumab Did Not Improve Invasive Disease-free Survival in Triple-negative Breast Cancer

December 7, 2012

SAN ANTONIO — Patients who received one year of bevacizumab in addition to chemotherapy for the postsurgical treatment of triple-negative...

Breast Cancer Genome Sequencing Identified HER2 Mutations as Targets for Drug Treatment

December 7, 2012

SAN ANTONIO — An analysis of data from a series of studies documenting breast cancer genome sequencing has confirmed that HER2 mutations may be...

HDAC Inhibitors Sensitized Triple-negative Breast Cancer Cells to PARP Inhibition and Cisplatin Treatment

December 6, 2012

SAN ANTONIO — In-vitro exposure to an HDAC inhibitor indirectly impaired the ability of triple-negative breast cancer cells to repair damaged...

Diverse Genetic Alterations Found in Triple-negative Breast Cancers After Neoadjuvant Chemotherapy

December 6, 2012

SAN ANTONIO — Many different genetic alterations were detected in tumor cells left behind after patients with triple-negative breast cancer...

Chemotherapy After Complete Surgical Removal of Local or Regional Breast Cancer Recurrence Increased Survival Rates

December 6, 2012

SAN ANTONIO — Chemotherapy after surgery, or adjuvant chemotherapy, led to higher rates of disease-free and overall survival for women with...

Hypofractionated Radiotherapy Was Safe, Effective for Early Breast Cancer Treatment at 10-year Follow-up

December 6, 2012

SAN ANTONIO — Appropriately dosed hypofractionated radiotherapy was gentle on healthy tissues and effective in controlling local-regional early...

Young Women With Breast Cancer Were More Likely Than Older Women to Respond to Neoadjuvant Chemotherapy

December 6, 2012

SAN ANTONIO — Women with breast cancer aged 35 or younger were more likely than older women to achieve a pathological complete response after...

Page:   1 2 3 4 5 6 7 8 9 10  next
Results Per Page